Aaron G.L. Fletcher - Director, 10%+ Owner at Cognition Therapeutics Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
Director, 10%+ Owner
Stock Symbol
CGTX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Aaron G.L. Fletcher since 11/5/2023

Holdings reported by Aaron G.L. Fletcher for Cognition Therapeutics Inc

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 2.02M $3.94M $1.95 Jun 7, 2024 By Bios Fund III QP, LP
Common Stock 1.42M $2.78M $1.95 Jun 7, 2024 By Bios Memory SPV I, LP
Common Stock 500K $975K $1.95 Jun 7, 2024 By Bios Clinical Opportunity Fund, LP
Common Stock 419K $817K $1.95 Jun 7, 2024 By Bios Fund I, LP
Common Stock 385K $751K $1.95 Jun 7, 2024 By Bios Memory SPV II, LP
Common Stock 327K $637K $1.95 Jun 7, 2024 By Bios Fund III NT, LP
Common Stock 310K $604K $1.95 Jun 7, 2024 By Bios Fund III, LP
Common Stock 256K $499K $1.95 Jun 7, 2024 By Bios Fund II QP, LP
Common Stock 245K $478K $1.95 Jun 7, 2024 By Bios Fund I QP, LP
Common Stock 78.3K $153K $1.95 Jun 7, 2024 By Bios Fund II, LP
Common Stock 34.2K $66.8K $1.95 Jun 7, 2024 By Bios Fund II NT, LP
Common Stock 14.5K $28.3K $1.95 Jun 7, 2024 Direct
Stock Option (right to buy) 8.5K Jun 7, 2024 Direct Common Stock 6K

Transactions reported by Aaron G.L. Fletcher for Cognition Therapeutics Inc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.